The role of proprotein convertase subtilisin/kexin type 9 inhibitors in managing cardiovascular risk

Natalie Schellack*, Gustav Schellack, E. Bronkhorst

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'The role of proprotein convertase subtilisin/kexin type 9 inhibitors in managing cardiovascular risk'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences